NAMPT and Insulin resistance: Visfatin, identified as the extracellular form of nicotinamide-phosphate ribosyl transferase (NAMPT), has been known to mediate insulin resistance and inflammation via binding to the insulin receptor or the innate immune receptor TLR-4.